News
Specializing in engineered gamma-delta T cells, Adicet Bio is poised to potentially reshape the landscape of treatments for autoimmune diseases and certain cancers. As the company progresses ...
Specializing in engineered gamma-delta T cells, Adicet Bio is poised to potentially reshape the landscape of treatments for autoimmune diseases and certain cancers. As the company progresses through ...
Gamma delta (γδ) T cells represent a unique lymphocyte subset in ruminants that bridge innate and adaptive immunity. In cattle, sheep and goats these cells not only circulate in the blood but ...
including difficult-to-engineer cell types such as gamma-delta T cells, T regulatory cells, dendritic cells, macrophages, natural killer cells and neutrophils which are being developed as ...
including difficult-to-engineer cell types such as gamma-delta T cells, T regulatory cells, dendritic cells, macrophages, natural killer cells and neutrophils which are being developed as ...
“These early data highlight the potential of repeated intracranial dosing of IN8bio’s gamma-delta T cells to extend mPFS in GBM, including in patients with chemotherapy-resistant tumors.
Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...
HOUSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for ...
CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
Researchers conducted this observational study to investigate the safety of CD19-targeting CAR T-cell therapy in patients with autoimmune diseases. They included 39 patients (median age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results